Posted on Leave a comment

FDA approves new drug Doptelet (avatrombopag) for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure

Spread the love

https://wp.me/p38LX5-5DK

Advertisements

This site uses Akismet to reduce spam. Learn how your comment data is processed.